Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Pharmacology & Therapeutics
|
February 25, 2017
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Oncotarget
|
January 10, 2018
Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
Alessia Fidoamore, Loredana Cristiano, Chiara Laezza, et al.
Scientific Reports
|
September 17, 2017
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer
Maria Chiara Proto, Donatella Fiore, Chiara Piscopo, et al.
Experimental Cell Research
|
December 14, 2005
Anandamide inhibits adhesion and migration of breast cancer cells
Claudia Grimaldi, Simona Pisanti, Chiara Laezza, et al.
British Journal of Pharmacology
|
April 19, 2017
The isoprenoid derivative N<sup>6</sup> -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway
Elena Ciaglia, Manuela Grimaldi, Mario Abate, et al.
Immunology Letters
|
March 16, 2007
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells
Anna Maria Malfitano, Gokce Altay Toruner, Patrizia Gazzerro, et al.
Cells
|
April 3, 2020
Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer
Daniela Criscuolo, Rosario Avolio, Giovanni Calice, et al.
Oncology Reports
|
December 4, 2009
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin
Patrizia Gazzerro, Anna M Malfitano, Maria Chiara Proto, et al.
International Journal of Molecular Sciences
|
October 13, 2021
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition
Cristina Pagano, Giovanna Navarra, Olga Pastorino, et al.
Oncotarget
|
May 27, 2015
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Pharmacology & Therapeutics
|
February 25, 2017
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Oncotarget
|
January 10, 2018
Energy metabolism in glioblastoma stem cells: PPARα a metabolic adaptor to intratumoral microenvironment
Alessia Fidoamore, Loredana Cristiano, Chiara Laezza, et al.
Scientific Reports
|
September 17, 2017
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer
Maria Chiara Proto, Donatella Fiore, Chiara Piscopo, et al.
Experimental Cell Research
|
December 14, 2005
Anandamide inhibits adhesion and migration of breast cancer cells
Claudia Grimaldi, Simona Pisanti, Chiara Laezza, et al.
British Journal of Pharmacology
|
April 19, 2017
The isoprenoid derivative N<sup>6</sup> -benzyladenosine CM223 exerts antitumor effects in glioma patient-derived primary cells through the mevalonate pathway
Elena Ciaglia, Manuela Grimaldi, Mario Abate, et al.
Immunology Letters
|
March 16, 2007
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells
Anna Maria Malfitano, Gokce Altay Toruner, Patrizia Gazzerro, et al.
Cells
|
April 3, 2020
Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer
Daniela Criscuolo, Rosario Avolio, Giovanni Calice, et al.
Oncology Reports
|
December 4, 2009
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin
Patrizia Gazzerro, Anna M Malfitano, Maria Chiara Proto, et al.
International Journal of Molecular Sciences
|
October 13, 2021
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition
Cristina Pagano, Giovanna Navarra, Olga Pastorino, et al.
Oncotarget
|
May 27, 2015
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Page
of 10